Cloudbreak Pharma Inc. - B Stock: price and insider trades · Hong Kong
Cloudbreak Pharma Inc. - B: what insiders have been doing
Every trade that managers of Cloudbreak Pharma Inc. - B disclose to HKEX is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 31 October 2026, brought 3 filings signed by 3 insiders.
The flow runs one way only: 3 sales, from 3 insiders, and no purchase. No amount is published for 3 filings, which the totals therefore leave out.
Across the 1,323 companies tracked on its exchange, the median is 4 filings; at 3 filings, this issuer sits below that mark. Our records for Cloudbreak Pharma Inc. - B go back to 2026, with no purchases and 3 sales on the open market in total.
Typically, a trade is published a median of 9 days after it takes place. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleFinancial data
as of FY 2025FY ended December 2025 · cache
- 905,826 sharesShareXHKGHKEX:DA20260410E00758
- 905,826 sharesShareXHKGHKEX:DA20260410E00001
- 7,607,943 sharesShareXHKGHKEX:DA20260409E00058
3 of 3 declarations
About Cloudbreak Pharma Inc. - B
Cloudbreak Pharma Inc. - B is a company operating in the healthcare and pharmaceutical sector, listed on the Hong Kong Stock Exchange. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations